American Society of Gene & Cell Therapy

10/23/2026

Next week is Epidermolysis Bullosa Awareness Week, a time to raise awareness about this group of rare genetic conditions that primarily affect the skin. Exciting advances in cell and gene therapy are creating new possibilities for people living with EB.

Learn more about the different types of EB, the current and emerging CGT treatments, and more on our website: https://bit.ly/4iVmEsx.

10/22/2026

We're proud to congratulate nine ASGCT members recently elected to the National Academy of Medicine, one of the highest honors in health and medicine.

This distinguished group of scientists and clinicians has helped drive groundbreaking discoveries and innovations that are transforming cell and gene therapy.

Please join us in celebrating:

• Carsten Gerhart Bönnemann, MD, habil.
• Terry Flotte, MD
• Don Kohn, MD, MS
• Maciej Lesniak, MD, MHCM, FAANS
• Alexander Marson, MD, PhD
• Nicola J. Mason, BVetMed, PhD, DACVIM, FRCVS
• Kiran Musunuru, MD, PhD, MPH, ML, MRA
• Luigi Naldini, MD, PhD (International inductee)
• Katy Rezvani, MD, PhD

Congratulations on this well-deserved recognition and thank you for your contributions to improving human health.

10/21/2026

Hot off the press! Our Q3 2026 Gene, Cell and RNA Therapy Landscape Report is now available!

Developed in partnership with Citeline, this one-of-a-kind, field-wide report explores the latest developments in gene, cell, and RNA therapies, including seven new approvals, an expanding clinical pipeline, and advancements shaping the future of patient care.

Read the full report for the latest insights: https://bit.ly/4ufliLp

10/20/2026

One month to go until a full day of Safety, Translation, and Real-World Implementation of AAV and LNP Gene Therapies.

On Nov. 20, ASGCT and the Clinical In Vivo Gene Therapy group at Children’s Hospital of Philadelphia are bringing experts together to explore the safety, translation and real-world implementation of AAV and LNP in vivo gene therapies.

Hear practical insights from experts working across clinical and translational settings, explore considerations that span specialties and earn CME credit along the way.

Save your seat: https://bit.ly/4uK4PPz

10/19/2026

Rare diseases present unique challenges, but advances in gene and cell therapy are creating new possibilities for patients worldwide.

Join Molecular Therapy on Oct. 21 for a free webinar exploring how scientific innovation is shaping therapeutic development for rare and ultra-rare diseases.

Hear from experts in rare disease research, gene therapy development, and clinical translation about the progress being made and the challenges that remain.

Register now: https://bit.ly/45qyPWl

10/19/2026

Thank you to our planning committee, speakers, panelists, and attendees for a fantastic Advancing Cell + Gene Therapies for Cancer program last week! The program highlighted the innovative approaches reshaping cancer treatment.

In case you missed us, on-demand access is now available for purchase ➡️ https://bit.ly/4zC9rd5

10/15/2026

The story doesn't end when treatment does.

Some of the most valuable cell and gene therapy data come years later. Join leading experts, institutions, and patient advocates to discuss long-term outcomes, patient engagement, real-world evidence, and what these lessons mean for the future of therapy development.

📅 December 2-3, 2026
💻 Virtual Event

Learn more and register: https://bit.ly/4e785ig

During this two half-day virtual program, clinicians, researchers, health system leaders, and patient advocates will examine the long-term experience of…

10/14/2026

This Health Literacy Awareness Month, we're celebrating the importance of helping people find, understand, and use health information to make informed decisions.

As cell and gene therapies continue to advance, access to accurate, reliable, and easy-to-understand information is more important than ever. The ASGCT Patient Education website serves as a trusted, neutral source for patients, families, and the public, offering resources on cell and gene therapy, clinical trials, rare diseases, and more.

Visit patienteducation.asgct.org to:

✅ Explore patient-friendly resources
✅ Download our CGT coloring book
✅ Subscribe to The Patient Press newsletter to stay informed

10/13/2026

What do people who have undergone transformative treatment for sickle cell disease wish they had known beforehand? In this special edition of Around the World, members of the sickle cell community share honest, firsthand experiences with bone marrow transplantation and gene therapy. Hear perspectives on making treatment decisions, preparing for therapy, navigating recovery, finding support, and life beyond treatment.

Watch the free webinar now to hear these personal perspectives on the realities of undergoing treatment: https://bit.ly/4s4d21e

Thank you to our speakers who participated in this webinar:

Jimi Olaghere
Zainab Garba-Sani
Maite Rodriguez
Dick Nchang
Matthew Porteus, PhD

10/13/2026

🎙️ Listen to the latest episode of The Issue podcast! This month, we welcomed Jerry McLaughlin, CEO of Life Biosciences, to talk about how epigenetic reprogramming could restore function in aging and injured cells.

McLaughlin also explains the science behind ER-100, an investigational gene therapy now in a Phase 1 trial for optic neuropathies, and explores the broader promise of targeting age-related diseases to help improve quality of life.

Listen now: https://bit.ly/4zxckfq